Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines.

Abstract:

BACKGROUND:Lactic acid bacteria (LAB) are beneficial probiotic organisms that contribute to improved nutrition, microbial balance, and immuno-enhancement of the intestinal tract, as well as anti-tumor activity. The aim of the present work was to study the growth inhibition of tumor cells by butanol extract of Bifidobacterium adolescentis isolated from healthy young Koreans. METHODS:The anti-proliferative activity of B. adolescentis isolates was assessed by XTT assays on three human colon cancer cell lines (Caco-2, HT-29, and SW480). The effects of B. adolescentis SPM0212 butanol extract on tumor necrosis factor-alpha (TNF-alpha) and nitric oxide (NO) production were tested using the murine macrophage RAW 264.7 cell line. RESULTS:The butanol extract of B. adolescentis SPM0212 dose-dependently inhibited the growth of Caco-2, HT-29, and SW480 cells by 70%, 30%, and 40%, respectively, at 200 microg/mL. Additionally, the butanol extract of B. adolescentis SPM0212 induced macrophage activation and significantly increased the production of TNF-alpha and NO, which regulate immune modulation and are cytotoxic to tumor cells. CONCLUSION:The butanol extract of B. adolescentis SPM0212 increased activity of the host immune system and may improve human health by helping to prevent colon cancer as a biological response modifier.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Lee DK,Jang S,Kim MJ,Kim JH,Chung MJ,Kim KJ,Ha NJ

doi

10.1186/1471-2407-8-310

subject

Has Abstract

pub_date

2008-10-27 00:00:00

pages

310

issn

1471-2407

pii

1471-2407-8-310

journal_volume

8

pub_type

杂志文章
  • Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.

    abstract:BACKGROUND:It is well known that osteopontin (OPN) plays an important role in tumor progression and that a high OPN expression level in several tumor entities correlates with poor prognosis in cancer patients. However, little is known about the prognostic relevance of the OPN mRNA splice variants. METHODS:We analyzed ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-131

    authors: Hahnel A,Wichmann H,Greither T,Kappler M,Würl P,Kotzsch M,Taubert H,Vordermark D,Bache M

    更新日期:2012-04-02 00:00:00

  • IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.

    abstract:BACKGROUND:Metastatic breast cancer carries a poor prognosis despite the success of newly targeted therapies. Treatment options remain especially limited for the subtype of triple negative breast cancer (TNBC). Several signaling pathways, including NF-κB, are altered in TNBC, and the complexity of this disease implies ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4507-2

    authors: House CD,Grajales V,Ozaki M,Jordan E,Wubneh H,Kimble DC,James JM,Kim MK,Annunziata CM

    更新日期:2018-05-25 00:00:00

  • Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review.

    abstract:BACKGROUND:The purpose of this review is to update previously published reviews on exercise programming in exercise trials in prostate cancer survivors. We evaluated: 1) the application of the principles of exercise training in prescribed programs; 2) the reporting of the components of the exercise prescription; and 3)...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5520-9

    authors: Neil-Sztramko SE,Medysky ME,Campbell KL,Bland KA,Winters-Stone KM

    更新日期:2019-04-05 00:00:00

  • The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis.

    abstract:BACKGROUND:Shared decision-making (SDM) is recommended for men facing prostate cancer (PC) screening decisions. We synthesize the evidence on the comparative effectiveness of SDM with usual care. METHODS:We searched academic and grey literature databases, and other sources for primary randomised controlled trials (RCT...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4794-7

    authors: Martínez-González NA,Neuner-Jehle S,Plate A,Rosemann T,Senn O

    更新日期:2018-10-22 00:00:00

  • Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report.

    abstract:BACKGROUND:Radium-223 has been shown to improve overall survival in men with metastatic castration-resistant prostate cancer with symptomatic bone metastases. The bone scan response to radium-223 has only been described in one single center trial of 14 patients, none of whom achieved the outstanding bone scan response ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1390-y

    authors: McNamara MA,George DJ

    更新日期:2015-05-07 00:00:00

  • Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells.

    abstract:BACKGROUND:The molecular chaperone, heat shock protein 90 (Hsp90) has been shown to be overexpressed in a number of cancers, including prostate cancer, making it an important target for drug discovery. Unfortunately, results with N-terminal inhibitors from initial clinical trials have been disappointing, as toxicity an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-468

    authors: Eskew JD,Sadikot T,Morales P,Duren A,Dunwiddie I,Swink M,Zhang X,Hembruff S,Donnelly A,Rajewski RA,Blagg BS,Manjarrez JR,Matts RL,Holzbeierlein JM,Vielhauer GA

    更新日期:2011-10-31 00:00:00

  • Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.

    abstract:BACKGROUND:For the expanding population of bladder cancer survivors in Korea, the development of subsequent cancers is a significant concern. Here, we provide the second primary cancer incidence rates and types in Korean patients with bladder cancer. METHODS:Using population-based data from the Korea Central Cancer Re...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4530-3

    authors: Kwon WA,Joung JY,Lim J,Oh CM,Jung KW,Kim SH,Seo HK,Park WS,Chung J,Lee KH,Won YJ

    更新日期:2018-05-31 00:00:00

  • Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells.

    abstract:BACKGROUND:Isothiocyanates are natural compounds found in consumable cruciferous vegetables. They have been shown to inhibit chemical carcinogenesis by a wide variety of chemical carcinogens in animal models. Recent studies have also shown that isothiocyanates have antitumor activity, inhibiting the growth of several t...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-269

    authors: Wu X,Zhu Y,Yan H,Liu B,Li Y,Zhou Q,Xu K

    更新日期:2010-06-09 00:00:00

  • The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies.

    abstract:BACKGROUND:The association between immune-related adverse events (irAEs) and survival outcomes in patients with advanced melanoma receiving therapy with immune checkpoint inhibitors (ICIs) has not been well established, particularly in Asian melanoma. METHODS:We retrospectively reviewed 49 melanoma patients undergoing...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07508-7

    authors: Wu CE,Yang CK,Peng MT,Huang PW,Chang CF,Yeh KY,Chen CB,Wang CL,Hsu CW,Chen IW,Lin CT,Ueng SH,Lin G,Lin YF,Cheng CY,Chang JW

    更新日期:2020-10-21 00:00:00

  • Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

    abstract:BACKGROUND:Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between ctDNA levels and the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4637-6

    authors: McEvoy AC,Warburton L,Al-Ogaili Z,Celliers L,Calapre L,Pereira MR,Khattak MA,Meniawy TM,Millward M,Ziman M,Gray ES

    更新日期:2018-07-09 00:00:00

  • CCC meets ICU: redefining the role of critical care of cancer patients.

    abstract:BACKGROUND:Currently the majority of cancer patients are considered ineligible for intensive care treatment and oncologists are struggling to get their patients admitted to intensive care units. Critical care and oncology are frequently two separate worlds that communicate rarely and thus do not share novel development...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-612

    authors: von Bergwelt-Baildon M,Hallek MJ,Shimabukuro-Vornhagen AA,Kochanek M

    更新日期:2010-11-08 00:00:00

  • Long-term follow-up results of simultaneous integrated or late course accelerated boost with external beam radiotherapy to vaginal cuff for high risk cervical cancer patients after radical hysterectomy.

    abstract:BACKGROUND:To assess the safety and efficacy of simultaneous integrated boost (SIB) or late course accelerated boost (LCAB) with external beam radiotherapy (EBRT) to the vaginal cuff for high risk cervical cancer patients after radical hysterectomy. METHODS:Between October 2009 and January 2012, patients with high ris...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1248-3

    authors: Wang X,Zhao Y,Shen Y,Shu P,Li Z,Bai S,Xu F

    更新日期:2015-04-11 00:00:00

  • Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.

    abstract:BACKGROUND:Neoadjuvant chemotherapy (NAC) is one of the standard care regimens for patients with resectable early-stage breast cancer. It would be advantageous to determine the chemosensitivity of tumors before initiating NAC. One of the parameters potentially compromising such chemosensitivity would be a hypoxic micro...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-400

    authors: Aomatsu N,Yashiro M,Kashiwagi S,Kawajiri H,Takashima T,Ohsawa M,Wakasa K,Hirakawa K

    更新日期:2014-06-04 00:00:00

  • Malignant transformation of vaginal adenosis to clear cell carcinoma without prenatal diethylstilbestrol exposure: a case report and literature review.

    abstract:BACKGROUND:We report an extremely rare case of vaginal clear cell carcinoma, which originated from the malignant transformation of vaginal adenosis without prenatal diethylstilbestrol (DES) exposure. CASE PRESENTATION:In this case, the patient was a Chinese woman with a history of two decades of intermittent vaginal p...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12885-019-6026-1

    authors: Pang L,Li L,Zhu L,Lang J,Bi Y

    更新日期:2019-08-13 00:00:00

  • The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.

    abstract:BACKGROUND:High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined inhibition of Bcl-2 an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5439-1

    authors: Klenke S,Akdeli N,Stelmach P,Heukamp L,Schulte JH,Bachmann HS

    更新日期:2019-03-18 00:00:00

  • UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?

    abstract:BACKGROUND:We conducted a case-control study to evaluate the role of UDP-glucuronosyltransferase 1A7 (UGT1A7) polymorphisms in the onset of hepatocellular carcinoma (HCC). METHODS:The study included 165 patients with HCC, 134 with cirrhosis and 142 controls without liver disease, matched for age and hospital. All were...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-214

    authors: Stücker I,Loriot MA,N'koutchou G,Cénée S,Bodin L,Mulot C,Gelu-Simeon M,Pelletier L,Bronowicki JP,Degos F,Beaune P,Laurent-Puig P,Hémon D,Trinchet JC,Pelletier G

    更新日期:2007-11-19 00:00:00

  • Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?

    abstract:BACKGROUND:The lymphocytes played an important role in the natural history of cancer. The aim of this study was to explore the prognostic value of lymphocyte count and percentage for survival in advanced cancer patients receiving palliative care. METHODS:A retrospective review of clinicopathological data from 378 cons...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3498-8

    authors: Zhao W,Wang P,Jia H,Chen M,Gu X,Liu M,Zhang Z,Cheng W,Wu Z

    更新日期:2017-08-02 00:00:00

  • Oligodendroglioma of the ciliary body: a unique case report and the review of literature.

    abstract:BACKGROUND:To date, there is no report in the international literature of an oligodendroglioma of the ciliary body, nor is there an analysis of the possible origins of this lesion. CASE PRESENTATION:Here we report on a 52-year-old man admitted to our hospital with a ciliary body tumor revealed by clinical examination ...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/1471-2407-10-579

    authors: Guo Q,Hao J,Sun Sb,Xu Sp,Yang Q,Guo Ql,Cui Gd

    更新日期:2010-10-23 00:00:00

  • Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.

    abstract:BACKGROUND:Colon cancer is the most common type of gastrointestinal cancer and has high morbidity and mortality. Colon adenocarcinoma (COAD) is the main pathological type of colon cancer, and much evidence has supported the correlation between the prognosis of COAD and the immune system. The current study aimed to deve...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07532-7

    authors: Luo J,Liu P,Wang L,Huang Y,Wang Y,Geng W,Chen D,Bai Y,Yang Z

    更新日期:2020-11-09 00:00:00

  • Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.

    abstract:BACKGROUND:Natural killer (NK) cell dysfunction following cancer surgery has been shown to promote metastases. Recent studies demonstrate an emerging role for lipids in the modulation of NK cell innate responses. However, the mechanisms involved in lipid modulation of NK cell postoperative anti-tumor function are unkno...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6045-y

    authors: Niavarani SR,Lawson C,Bakos O,Boudaud M,Batenchuk C,Rouleau S,Tai LH

    更新日期:2019-08-20 00:00:00

  • Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.

    abstract:BACKGROUND:Stimulation of vascular endothelial growth factor (VEGF) has been observed following transarterial chemoembolization (TACE) in hepatocellular cancer (HCC) and may contribute to tumor regrowth. This pilot study examined whether intravenous (IV) bevacizumab, a monoclonal antibody against VEGF, could inhibit ne...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/1471-2407-12-16

    authors: Britten CD,Gomes AS,Wainberg ZA,Elashoff D,Amado R,Xin Y,Busuttil RW,Slamon DJ,Finn RS

    更新日期:2012-01-14 00:00:00

  • Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma.

    abstract:BACKGROUND:Cancer cell repopulation during chemotherapy or radiotherapy is a major factor limiting the efficacy of treatment. Cancer stem cells (CSC) may play critical roles during this process. We aim to demonstrate the role of mesothelioma stem cells (MSC) in treatment failure and eventually to design specific target...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4354-1

    authors: Wu L,Blum W,Zhu CQ,Yun Z,Pecze L,Kohno M,Chan ML,Zhao Y,Felley-Bosco E,Schwaller B,de Perrot M

    更新日期:2018-04-27 00:00:00

  • Classification tree analysis of second neoplasms in survivors of childhood cancer.

    abstract:BACKGROUND:Reports on childhood cancer survivors estimated cumulative probability of developing secondary neoplasms vary from 3.3% to 25% at 25 years from diagnosis, and the risk of developing another cancer to several times greater than in the general population. METHODS:In our retrospective study, we have used the c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-27

    authors: Jazbec J,Todorovski L,Jereb B

    更新日期:2007-02-02 00:00:00

  • Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.

    abstract:BACKGROUND:The expression of HER2, estrogen (ER) and progesterone (PR) receptor can change during the course of the disease in breast cancer (BC). Therefore, reassessment of these markers at the time of disease progression might help to optimize treatment decisions. In this context, characterization of circulating tumo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2587-4

    authors: Aktas B,Kasimir-Bauer S,Müller V,Janni W,Fehm T,Wallwiener D,Pantel K,Tewes M,DETECT Study Group.

    更新日期:2016-07-25 00:00:00

  • The prognostic effect of perineural invasion in esophageal squamous cell carcinoma.

    abstract:BACKGROUND:Perineural invasion (PNI) is correlated with adverse survival in several malignancies, but its significance in esophageal squamous cell carcinoma (ESCC) remains to be clearly defined. The objective of this study was to determine the association between PNI status and clinical outcomes. METHODS:We retrospect...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-313

    authors: Chen JW,Xie JD,Ling YH,Li P,Yan SM,Xi SY,Luo RZ,Yun JP,Xie D,Cai MY

    更新日期:2014-05-05 00:00:00

  • Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.

    abstract:BACKGROUND:Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) are promising cancer drugs currently in clinical trials in oncology, including APO866, CHS-828 and the CHS-828 prodrug EB1627/GMX1777, but cancer cell resistance to these drugs has not been studied in detail. METHODS:Here, we introduce an analogue...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-677

    authors: Olesen UH,Petersen JG,Garten A,Kiess W,Yoshino J,Imai S,Christensen MK,Fristrup P,Thougaard AV,Björkling F,Jensen PB,Nielsen SJ,Sehested M

    更新日期:2010-12-12 00:00:00

  • Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.

    abstract:BACKGROUND:Long-term survival in numerous cancers often correlates with specific whole transcriptome profiles or the expression patterns of smaller numbers of transcripts. In some instances, these are better predictors of survival than are standard classification methods such as clinical stage or hormone receptor statu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06756-x

    authors: Mandel J,Avula R,Prochownik EV

    更新日期:2020-04-07 00:00:00

  • Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death in the world. N6-methyladenosine (m6A) RNA methylation is dynamically regulated by m6A RNA methylation modulators ("writer," "eraser," and "reader" proteins), which are associated with cancer occurrence and development. Th...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6638-5

    authors: Qu N,Qin S,Zhang X,Bo X,Liu Z,Tan C,Wen G,Jiang H

    更新日期:2020-02-28 00:00:00

  • Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion.

    abstract:BACKGROUND:Li-Fraumeni (LFS) and Li-Fraumeni-like (LFL) syndromes are associated to germline TP53 mutations, and are characterized by the development of central nervous system tumors, sarcomas, adrenocortical carcinomas, and other early-onset tumors. Due to the high frequency of breast cancer in LFS/LFL families, these...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-237

    authors: Silva AG,Ewald IP,Sapienza M,Pinheiro M,Peixoto A,de Nóbrega AF,Carraro DM,Teixeira MR,Ashton-Prolla P,Achatz MI,Rosenberg C,Krepischi AC

    更新日期:2012-06-12 00:00:00

  • Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.

    abstract:BACKGROUND:First-line treatment with FOLFOXIRI plus bevacizumab (BEV) is highly effective and regarded as one of the standards-of-care for patients with metastatic colorectal cancer (mCRC), despite the high incidence of neutropenia and diarrhea as side effects. AXEPT, an Asian phase III study, showed that modified CAPI...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07186-5

    authors: Miyo M,Kato T,Yoshino T,Yamanaka T,Bando H,Satake H,Yamazaki K,Taniguchi H,Oki E,Kotaka M,Oba K,Miyata Y,Muro K,Komatsu Y,Baba H,Tsuji A

    更新日期:2020-07-23 00:00:00